STOCK TITAN

Akebia Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Akebia Therapeutics, Inc. (Nasdaq: AKBA) CEO to present at 42nd Annual J.P. Morgan Healthcare Conference
Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Dec. 20, 2023 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11th, 2024 at 11:15 a.m. PST.

The 42nd Annual J.P. Morgan Healthcare Conference will take place January 8 – 11, 2024, in San Francisco, CA.

A webcast of the presentation can be accessed through the "Investors" section of Akebia's website at https://ir.akebia.com for 30 days following the conference.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302019671.html

SOURCE Akebia Therapeutics, Inc.

FAQ

When will the CEO of Akebia Therapeutics, Inc. present at the 42nd Annual J.P. Morgan Healthcare Conference?

John Butler, Chief Executive Officer, will present on Thursday, January 11th, 2024 at 11:15 a.m. PST.

Where will the 42nd Annual J.P. Morgan Healthcare Conference take place?

The conference will take place January 8 – 11, 2024, in San Francisco, CA.

How can the webcast of the presentation be accessed?

The webcast can be accessed through the 'Investors' section of Akebia's website at https://ir.akebia.com for 30 days following the conference.

Akebia Therapeutics, Inc.

NASDAQ:AKBA

AKBA Rankings

AKBA Latest News

AKBA Stock Data

404.73M
207.87M
2.09%
27.37%
5.48%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
CAMBRIDGE